Peptide therapy TikTok claims: separating signal from hype

What's this video probably claiming?

Based on the peptide category tag and the creator's posting history, this video likely promotes one or more peptides, possibly BPC-157, TB-500, CJC-1295, ipamorelin, or GHK-Cu, as tools for accelerated recovery, fat loss, anti-aging, or muscle growth. Creators in this space typically frame peptides as cutting-edge compounds that mainstream medicine ignores, positioning them as accessible through telehealth or gray-market peptide suppliers. The tone is usually personal testimony mixed with surface-level mechanistic explanation, something like "BPC-157 healed my gut in two weeks" or "CJC-1295 plus ipamorelin changed my sleep and body composition." The claims sound plausible because peptides do have real biological activity. The problem is that plausible mechanism and proven clinical outcome are not the same thing, and TikTok creators reliably conflate the two.

What does the science actually show?

The honest answer is: a lot less than the content suggests, at least in humans. BPC-157 has interesting rodent data. Chang et al. (2011, Journal of Physiology-Paris) showed accelerated tendon healing in rats at doses around 10 mcg/kg. Impressive. But there are zero completed Phase II or Phase III human trials. TB-500, or its active fragment TB4-frag, is similarly stuck in preclinical work. CJC-1295 with DAC does increase IGF-1 levels in humans. Ionescu et al. (2013, Journal of Clinical Endocrinology and Metabolism) documented IGF-1 elevations of roughly 50-100% over baseline with weekly dosing, but the trial population was adults with growth hormone deficiency, not healthy biohackers. Ipamorelin has a decent safety profile in short-term studies but long-term data past 12 weeks in healthy adults essentially does not exist. GHK-Cu topical data is the most strong for skin applications, but systemic claims are largely extrapolated from in vitro work.

Where does the social media noise diverge from clinical reality?

The biggest gap is the extrapolation problem. A peptide that repairs tendon tissue in a rat model at a controlled dose, in a sterile lab setting, is not the same as a lyophilized powder you reconstitute yourself and inject subcutaneously based on a Reddit thread. The route of administration matters. Oral BPC-157 has almost no bioavailability data supporting systemic effects. Injectable versions used outside clinical supervision carry real infection risk, and compounded peptides are not FDA-approved, meaning potency and sterility are not guaranteed. MK-677, which is not technically a peptide but gets lumped in, is particularly misrepresented. It raises growth hormone and IGF-1, yes, but Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) documented meaningful increases in fasting glucose and insulin resistance at 25 mg daily in older adults. Creators almost never mention this. The "no side effects" framing is a recurring problem across this entire content category.

What should you actually know?

Peptide therapy is a legitimate area of clinical research, and some peptides are prescribed legally through regulated telehealth providers for specific indications. That context matters. What is not legitimate is using TikTok testimonials as a substitute for clinical evaluation, or sourcing peptides from unregulated suppliers. If a creator does not mention that most of these compounds are either unapproved for human use or only appropriate in specific clinical contexts, that is a gap worth noticing. Semax and selank, Soviet-era nootropic peptides, have almost no English-language clinical data whatsoever. Their presence in a peptide stack video should prompt immediate skepticism. The science on peptides is genuinely interesting. The social media version of it strips out every caveat, every contraindication, and every honest acknowledgment of what we simply do not know yet. That gap is where people get hurt.